Navigation Links
High Profile HealthCare Companies: Leading Pharma Company Secures New Patents
Date:2/14/2013

rter of 2013.

Eli Lilly and Company (NYSE: LLY) closed up slightly in trading yesterday closing at $53.44 per share on 4.38Million shares.  An announcement was issued after the close yesterday that LLY has entered into a master collaboration agreement with QIAGEN (NASDAQ: QGEN) for the development and commercialization of companion diagnostics for pairing with Lilly investigational and approved medicines across all therapeutic areas. The agreement builds on QIAGEN and Lilly's past work together. Companion diagnostics unlock a patient's molecular information in order to guide treatment decisions for specific cancers or other diseases. Financial terms of the agreement are not being disclosed.

Medtronic, Inc. (NYSE: MDT) closed down slightly in trading yesterday closing at $46.99 per share on 3.04Million shares, but was up in After-Market trading.  MDT announced after the markets closed on Wednesday that it has received Food and Drug Administration (FDA) clearance for its AIRvance(TM) Bone Screw System that allows surgeons to perform a hyoid suspension procedure independently or in combination with other procedures for the treatment of obstructive sleep apnea (OSA). Under the previous FDA clearance the hyoid suspension procedure was indicated as an adjunct to the tongue suspension procedure. This latest FDA clearance makes the AIRvance System the only combined system available for performing a hyoid suspension procedure as well a tongue suspension procedure.

RPX Corporation (NASDAQ: RPXC) closed up over 22% in trading yesterday closing at $13.05 pre share on 1.1Million shares.  RPXC is a leading provider of patent risk management solutions, announced yesterday its financial results for t
'/>"/>

SOURCE FinancialNewsMedia.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com
2. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
3. Group Florence Nightingale Increases Radiosurgery Profile with Acquisition of Turkeys First Leksell Gamma Knife Perfexion System
4. NKTR-192, A New Short-Acting Mu-Opioid Analgesic Molecule, Achieves Desired Pharmacokinetic Profile in First Phase 1a Clinical Study
5. Abaxis Announces the Launch of Kidney Profile Plus Panel
6. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
7. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
8. Patient Safety, Science and Technology Summit Inspires Healthcare Industry Stakeholders to Action in Pursuit of 0 Preventable Patient Deaths by 2020
9. Hill-Rom to Participate in the 2013 Citi Global Healthcare Conference
10. Dynamic Healthcare Services Names Senior Level Management Team
11. Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 /CNW Telbec/ - KLOX Technologies Inc. ("KLOX" or ... Todd Martensen has been ... role of Chief Commercial Officer, to oversee KLOX,s commercial ... gel for the treatment of chronic and other hard-to-heal ... approved in Europe . Mr. Martensen, ...
(Date:11/21/2014)... November 2014 Michael DeMarco (42) ... des 14. Februar 2014 zugetragen hat. Seine Tochter Aly ... Video - http://youtu.be/5cVoMCe0uiE ... mein morgendliches Training zu machen", erzählt Michael DeMarco ... Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf ...
(Date:11/21/2014)... 2014   Coqui RadioPharmaceuticals Corp. , a medical ... producer of Molybdenum-99 (Mo-99), is proud to announce it ... to design its Medical Isotope Production Facility (MIPF) in ... parent isotope of Technetium-99, which is used in 80 ... passed legislation making it a national priority to produce ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2
... In Children,s DNA, a Hint of a Mutation,s Ancestral ... researchers,seeking to replicate another group,s discovery of an important ... a particular,variant in DNA that may be more helpful ... populations worldwide. The finding suggests that,the gene variant, identified ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) announced ... clinical study of ANX-510, CoFactor(R), for the treatment ... at the 2008,American Society of Clinical Oncology (ASCO) ... 3, 2008 in Chicago, IL., The poster ...
Cached Medicine Technology:Gene Hunters Fine-Tune Marker for Common Obesity Gene 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 3ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) 2ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) 3
(Date:11/22/2014)... November 22, 2014 A new ... announced today which safely detects and identifies hazards ... radio waves. Developed by RHT SpectraSafe, the technology ... broad applications in other areas including medical, recycling, ... , Using high frequency radio waves that pass ...
(Date:11/22/2014)... November 22, 2014 “Greenfield Naturals” was ... Tech Report , which features the latest and coolest ... expert and reporter for NewsWatch, conducted the product review ... the flavor of your water. , From pollution to ... important that everything is done to remove these chemicals, ...
(Date:11/22/2014)... OH (PRWEB) November 22, 2014 A Xarelto ... York woman who is seeking $10 million in damages from ... thinner . According to the lawsuit, the woman began using ... The woman alleges in her lawsuit she suffered life-threatening bleeding ... permanent personal injuries, pain, suffering and emotional distress. The lawsuit ...
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- Many young ... smoke, but a new study finds fumes from the ... been linked to an increased risk for leukemia in ... 21 in the journal Cancer Epidemiology, Biomarkers & ... hookah tobacco smoking is not a safe alternative to ...
(Date:11/22/2014)... Steven Reinberg HealthDay Reporter ... are better when patients are treated in an ambulance by ... German researchers report. The sooner patients get the clot ... outcome after a stroke, the researchers noted. For the best ... hour after stroke symptoms start, the researchers said. "The ...
Breaking Medicine News(10 mins):Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3
... Simon Fraser University, has made a discovery that will change ... treated. The journal Nature has just ... and mutational evolution spectrum of primary triple negative breast cancers. ... what were thought to be triple negative breast cancer tumours. ...
... red wine, grapes and other fruits, and similar in structure ... fat cells to develop, opening a door to a potential ... Kee-Hong Kim, an assistant professor of food science, and ... in this week,s issue of the Journal of Biological ...
... April 4 (HealthDay News) -- Large amounts of lifetime ... result in post-traumatic stress disorder -- boosts inflammation levels ... The findings are important because it,s known that heart ... fare worse, according to the researchers at the University ...
... By Steven Reinberg HealthDay Reporter , ... vaccine appears to lengthen the lives of patients with ... of a small phase 2 trial. The drug, ... non-small cell lung cancer and increased the five-year survival ...
... patients with non-small cell lung cancer for both mutations and ... to predict response to treatment with antifolates, according to the ... Annual Meeting 2012, held here March 31 - April 4. ... gene mutations have a worse prognosis and do not respond ...
... CHICAGO, IL (April 4, 2012)When combined with other treatments, ... growth of cancer cellshas been shown to extend survival ... Unfortunately, about 40 percent of colorectal cancer patientsspecifically ... called KRASdo not respond to the drug. Researchers ...
Cached Medicine News:Health News:Scientists uncover multiple faces of deadly breast cancer 2Health News:Red wine, fruit compound could help block fat cell formation 2Health News:Witnessing, Experiencing Traumatic Events May Worsen Heart Disease 2Health News:Early Study Finds Some Promise for Lung Cancer Vaccine 2Health News:KRAS gene mutation and amplification status affects sensitivity to antifolate therapy 2Health News:Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance 2
... Immunosimplicity (Is) Rubella IgG Test Kit ... qualitative and quantitative detection of antibodies ... performed either manually or in conjunction ... The results are reported in IU/ml,which ...
... VITROS HBsAg assay is the ... the U.S. Food and Drug,Administration ... a random,access format on the ... Now you can run an,HBsAg ...
... as a quality assurance reagent ... (IgM) antibodies to hepatitis B ... antibodies to hepatitis A virus ... antigen (HBeAg) and total antibody ...
... antibody gives positive staining of prostatic ... hyperplasia. In cases of prostatic cancer, ... give definite but weak staining or ... cells; this pattern of staining permits ...
Medicine Products: